Guenther H L, Hofstetter W, Moseley J M, Gillespie M T, Suda N, Martin T J
Department of Pathophysiology, University of Berne, Switzerland.
Bone. 1995 Mar;16(3):341-7. doi: 10.1016/8756-3282(94)00047-6.
Parathyroid hormone-related protein (PTHrP) is synthesized by a variety of tumors and is thought to be the main cause of the clinical syndrome of humoral hypercalcemia of malignancy (HHM). In addition to its parathyroid hormone (PTH)-like actions, novel actions of PTHrP on placental calcium transport and inhibition of in vitro osteoclast activity have been demonstrated. The fact that osteoblasts act as mediators of osteoclastic bone resorption prompted us to investigate whether nontranformed, osteoblastlike cells produce PTHrP. PTHrP has been detected in developing human fetal bones and in rat long bones in culture. For this study, osteogenic cells, CRP 5/4 and CRP 10/30, were employed. Both cell types represent clonal bone cell populations established from 1-day-old rats. While CRP 10/30 cells express the osteoblastic phenotype, CRP 5/4 cells resemble cells with preosteoblastic properties. With a radioimmunoassay (RIA), utilizing antiserum directed against the amino-terminal PTHrP(1-40), it was found that both cell types synthesize PTHrP constitutively. CRP 10/30 cells produce about twice as much as CRP 5/4 cells. Transforming growth factor-beta (TGF-beta 1) was shown to increase the synthesis of PTHrP in CRP 5/4 cells by about 2.5-fold, while in CRP 10/30 cells it caused an approximate 50% reduction of PTHrP. Employing the reverse transcriptase polymerase chain reaction (RT-PCR) technique it was found that both bone cell types express mRNA for PTHrP and that the modulation of the PTHrP mRNA levels by TGF-beta 1 in CRP 5/4, and to a lesser degree in CRP 10/30 cells, was reflected in a change in the level of PTHrP protein in the culture medium.(ABSTRACT TRUNCATED AT 250 WORDS)
甲状旁腺激素相关蛋白(PTHrP)由多种肿瘤合成,被认为是恶性肿瘤体液性高钙血症(HHM)临床综合征的主要病因。除了其类似甲状旁腺激素(PTH)的作用外,PTHrP对胎盘钙转运和体外破骨细胞活性抑制的新作用也已得到证实。成骨细胞作为破骨细胞骨吸收的介质这一事实促使我们研究未转化的成骨样细胞是否产生PTHrP。在发育中的人类胎儿骨骼和培养的大鼠长骨中已检测到PTHrP。在本研究中,使用了成骨细胞CRP 5/4和CRP 10/30。这两种细胞类型均代表从1日龄大鼠建立的克隆性骨细胞群体。虽然CRP 10/30细胞表达成骨细胞表型,但CRP 5/4细胞类似于具有前成骨细胞特性的细胞。通过使用针对氨基末端PTHrP(1-40)的抗血清进行放射免疫测定(RIA),发现这两种细胞类型均组成性地合成PTHrP。CRP 10/30细胞产生的量约为CRP 5/4细胞的两倍。已表明转化生长因子-β(TGF-β1)可使CRP 5/4细胞中PTHrP的合成增加约2.5倍,而在CRP 10/30细胞中,它导致PTHrP减少约50%。采用逆转录酶聚合酶链反应(RT-PCR)技术发现,两种骨细胞类型均表达PTHrP的mRNA,并且TGF-β1对CRP 5/4细胞中PTHrP mRNA水平的调节,以及在较小程度上对CRP 10/30细胞中PTHrP mRNA水平的调节,反映在培养基中PTHrP蛋白水平的变化上。(摘要截短于250字)